Patent. CN114053270A 【IF: 0】Patent. CN114053270A 2022 Feb 18 MG132 purchased from AbMole
Patent. AU2020419444A1 【IF: 0】Patent. AU2020419444A1 2022 Jun 09 Ipilimumab purchased from AbMole
Development of novel anticancer agents targeting G protein coupled receptor: GPR120 【IF: 0】Technological University Dublin. 2022 Dec LDE225 (Sonidegib) diphosphate purchased from AbMole
Patent. CN114432450A 【IF: 0】Patent. CN114432450A 2022 May 06 666-15 purchased from AbMole
Patent. AU2019358428B2 【IF: 0】Patent. AU2019358428B2 2022 Aug 04 SBE-β-CD purchased from AbMole
Patent. WO2022173300A1 【IF: 0】Patent. WO2022173300A1 2022 Aug 18 Y-27632 dihydrochloride purchased from AbMole
Patent. WO2022262837A1 【IF: 0】Patent. WO2022262837A1 2022 Dec 22 Glucagon (1-29), bovine, human, porcine purchased from AbMole
Patent. CN114075538B 【IF: 0】Patent. CN114075538B 2022 Nov 25 Y-27632 dihydrochloride purchased from AbMole
Patent. US2022154143A1 【IF: 0】Patent. US2022154143A1 2022 May 19 Y-27632 dihydrochloride purchased from AbMole
Patent. CN114686433A 【IF: 0】Patent. CN114686433A 2022 Jul 01 Disulfiram purchased from AbMole
Patent. CN114886883A 【IF: 0】Patent. CN114886883A 2022 Aug 12 Sivelestat sodium tetrahydrate purchased from AbMole
Patent. AU2019426113B2 【IF: 0】Patent. AU2019426113B2 2022 Jun 16 Oclacitinib purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
